Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 9,40% of the shares and voting rights in IDEX. Sundt AS will hold 2,804,915 shares in IDEX. The ownership will represent 4,93% of the shares and voting rights in IDEX. About this notice: The information shall be ...

Financial Performance - IDEX Biometrics reported operating expenses excluding cost of materials and depreciation of $5.2 million for the first half of 2025, a 52% reduction compared to $10.7 million in the same period of 2024 [2] - The company had a net loss of $2.1 million for the quarter, with revenues of $0.1 million [2] - Cash balance as of June 30, 2025, was $1.0 million [2] Operational Changes - The company reduced its full-time equivalent staff from 59 on June 30, 2024, to 30 by the end of Q2 2025, resulting in a 73% reduction in compensation and benefits costs compared to the previous quarter [2] - A renegotiation of Heights convertible bond reduced the outstanding principal from approximately NOK 66.6 million to NOK 50.0 million, and further to approximately NOK 33.3 million in July [2] - The company aims to achieve a quarterly run rate of operating expenses between $1.5 million and $1.7 million by the end of Q3 2025 [2] Management and Governance - On June 1, 2025, IDEX strengthened its management team by appointing Kjell-Arne Besseberg as Chief Operating Officer [2] - On June 30, 2025, CEO Anders Storbråten also took on the role of CFO, consolidating the two positions to reduce costs and enhance focus on investor relations [2] - Employees, directors, and consultants subscribed for 299,381,600 shares totaling approximately NOK 3.0 million on June 15, 2025, to strengthen alignment of interests within the company [2] Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [1] - The company partners with leading card manufacturers and technology companies to bring its biometric solutions to market [1]

Core Insights - IDEX Biometrics ASA completed Tranche 2 of a private placement, involving 4,359,315 shares lent by CEO and CFO Anders Storbråten at a price of NOK 3.30 per share [1] - After the completion of Tranche 2, Anders Storbråten and close relations hold a total of 11,555,213 shares, representing 20.3% of the total outstanding shares and votes in IDEX Biometrics [2] Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3] - The company's biometric solutions are built on patented technologies and target card-based applications for payments and digital authentication, partnering with leading card manufacturers and technology companies [3]

Group 1 - IDEX Biometrics ASA conducted a private placement of 9,090,909 shares at NOK 3.30 per share, divided into two tranches [1] - In tranche 2, a total of 4,813,857 shares were included, which also accounted for underwriting shares [1] - Pinchcliffe AS and CEO Anders Storbråten subscribed to 469,255 and 703,883 shares respectively, resulting in Storbråten and close relations holding 7,195,898 shares, or 13.81% of total outstanding shares after tranche 2 [2] Group 2 - K-konsult AS, related to chair Morten Opstad, subscribed to 153,343 shares, while Opstad subscribed to 50,000 shares at the same price of NOK 3.30 per share [3] - IDEX Biometrics is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3] - The company collaborates with leading card manufacturers and technology firms to market its biometric solutions, which are based on proprietary sensor technologies and integrated circuit designs [3] Group 3 - The notice regarding the private placement was issued by COO Kjell-Arne Besseberg on 23 August 2025, in compliance with EU Market Abuse Regulation and Norwegian Securities Trading Act [4]

Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 10,26% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA) and published in accordance with section ...

Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. The share capital increase related to the Tranche 2 and underwriting shares have been registered and the shares will be delivered soonest. The Tranche 2 ander underwriting shares will be delivered on a separate and non-tradable ISIN, pending publication by the Company of aprospectus approved by the Norwegian Financial Supervisory Authority. Following ...

Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. In connection with the private placement, the manager of the private placement, IDEX Biometrics and Mr. Storbråten entered into a share lending agreement. Mr. Storbråten has lent 4,359,315 shares, in connection with the settlement of Tranche 2. The shares have been lent, not sold ...

IDEX Biometrics ASA held an extraordinary general meeting on 14 August 2025. All resolutions were passed as proposed in the notice and agenda update for the meeting. The minutes of the meeting will be available at the company's web site in due course. IDEX Biometrics' reports and presentations are available on our website: www.idexbiometrics.com/investors About IDEX Biometrics: IDEX Biometrics ASA (IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across paymen ...

Core Insights - IDEX Biometrics ASA announced a private placement of 9,090,909 shares at NOK 3.30 per share, with Tranche 1 consisting of 4,731,594 shares lent by CEO and CFO Anders Storbråten [1] - After the completion of Tranche 1, Anders Storbråten and close relations hold a total of 11,235,070 shares, representing 21.57% of the total outstanding shares and votes in IDEX Biometrics [2] Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [2] - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [2] - IDEX partners with leading card manufacturers and technology companies to bring its solutions to market [2]

Reference is made to the announcement by IDEX Biometrics ASA on 21 July 2025. Regarding a private placement of 9,090,909 shares at NOK 3,30 per shares into two tranches. The share capital increase of tranche 1, 4,731,594 shares, has duly been registered in the Norwegian Register of Business Enterprises. Following the share capital increase, the Company's share capital is NOK 52,095,850.00 divided into 52,095,850 shares, each with a nominal value of NOK 1.00. IDEX Biometrics' reports and presentations are av ...